Director
DIN: 02518391
Abhishek Singh is currently associated with 3 companies as Director. They serve as a Director at USM PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02518391.Abhishek Singh has previously been associated with 1 company in roles such as Director.Abhishek Singh is currently involved in 1 different role. Their most recent position is with PRASAD IDEAL REAL ESTATE DEVELOPERS PRIVATE LIMITED as a Director. The first company Abhishek Singh was appointed to as a director was USM PHARMACEUTICALS PRIVATE LIMITED. Abhishek Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Abhishek Singh is currently associated with 3 companies as Director. They serve as a Director at USM PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02518391.Abhishek Singh has previously been associated with 1 company in roles such as Director.Abhishek Singh is currently involved in 1 different role. Their most recent position is with PRASAD IDEAL REAL ESTATE DEVELOPERS PRIVATE LIMITED as a Director. The first company Abhishek Singh was appointed to as a director was USM PHARMACEUTICALS PRIVATE LIMITED. Abhishek Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (3)
Current LLPs (0)
Past Companies (1)
2y 10m 1y 5m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| USM PHARMACEUTICALS PRIVATE LIMITED | Director | 22-May-2012 |
| PRASAD IDEAL HEALTHCARE PRIVATE LIMITED | Director | 06-Jan-2023 |
| PRASAD IDEAL REAL ESTATE DEVELOPERS PRIVATE LIMITED | Director | 09-Jan-2023 |